Agilent Technologies, Inc. (A)

131,96 +0,83 (+0,63%) Börsenschluss: 04:03PM EDT

Agilent Technologies, Inc.

5301 Stevens Creek Boulevard
Santa Clara, CA 95051
United States
800 227 9770
https://www.agilent.com

Sektor(en): Healthcare
Branche: Diagnostics & Research
Vollzeitmitarbeiter: 18.300

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Michael R. McMullen	CEO, Pres & Director	3,66M	1,24M	1961
Mr. Robert W. McMahon	Sr. VP & CFO	1,54M	N/A	1969
Mr. Henrik Ancher-Jensen	Sr. VP and Pres of Order Fulfillment & Supply Chain	1,31M	N/A	1965
Mr. Jacob Thaysen	Sr. VP and Pres of Life Sciences & Applied Markets Group	1,46M	N/A	1975
Mr. Samraat S. Raha	Sr. VP and Pres of Diagnostics & Genomics Group	1,14M	N/A	1973
Mr. Rodney Gonsalves	Principal Accounting Officer, VP & Corp. Controller	N/A	N/A	1966
Dr. Darlene J. S. Solomon Ph.D.	CTO & Sr. VP	N/A	N/A	1959
Mr. Michael Tang	Sr. VP, Gen. Counsel & Sec.	N/A	N/A	1974
Mr. Dominique P. Grau	Sr. VP of HR & Global Communications	N/A	N/A	1959
Ms. Allison Ballmer	Sr. VP of Strategy & Corp. Devel.	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Corporate Governance

Agilent Technologies, Inc.s ISS Governance QualityScore, Stand 1. März 2023, lautet 8. Die grundlegenden Scores sind Audit: 10, Vorstand: 4, Shareholderrechte: 9, Kompensation: 4.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.